https://regulatorynews.com/biolinq-shine-otc-fda-clearance Regulatory News en 2026-09-26T09:30:29-04:00 Biolinq's Shine Clears FDA for OTC Sale https://regulatorynews.com/mirum-atebrioz-fop-approval Regulatory News en 2026-09-26T09:30:29-04:00 Mirum Wins FDA Nod for Third FOP Drug Atebrioz https://regulatorynews.com/precision-neuroscience-series-d-financing Regulatory News en 2026-09-26T09:30:29-04:00 Precision Neuroscience Raises $250M for BCI https://regulatorynews.com/fda-robotic-surgery-draft-guidance Regulatory News en 2026-09-26T05:57:37-04:00 FDA Drafts First Guidance for Surgical Robots https://regulatorynews.com/merck-welireg-lenvima-ccrcc-approval Regulatory News en 2026-09-26T05:57:37-04:00 FDA Clears Welireg-Lenvima Combo for Kidney Cancer https://regulatorynews.com/nezglyal-leriglitazone-cald-ec-approval Regulatory News en 2026-09-26T05:57:37-04:00 EU Approves First Drug for Cerebral ALD https://regulatorynews.com/bighat-biosciences-series-c-financing Regulatory News en 2026-09-25T09:35:57-04:00 BigHat Biosciences Lands $75M for AI Antibodies https://regulatorynews.com/xcovery-betta-gevalka-ensartinib-chmp-opinion Regulatory News en 2026-09-25T09:35:57-04:00 Betta's Gevalka Clears CHMP for Lung Cancer https://regulatorynews.com/grail-galleri-fda-panel-vote Regulatory News en 2026-09-25T05:53:10-04:00 FDA Panel Narrowly Backs GRAIL's Galleri Test https://regulatorynews.com/mhra-lurbinectedin-irp-approval Regulatory News en 2026-09-25T05:53:10-04:00 MHRA Approves Lurbinectedin Combo for Lung Cancer https://regulatorynews.com/mhra-medicina-ce-fraud-sentencing Regulatory News en 2026-09-25T05:53:10-04:00 Director Sentenced Over Fake CE-Marked Baby Devices